Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xigris in severe acute pancreatitis
2007-003635-23Phase 2Completed
- Sponsor
- Central Manchester and Manchester Children's Hospitals NHS Trust
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of drotrecogin alfa in acute pancreatitis (AP), sponsored by Central Manchester and Manchester Children's Hospitals NHS Trust. Primary endpoints: Safety of treatment, Markers of coagulation response and 1 more. Started Sep 2009; status: completed.
02
Drugs
drotrecogin alfa
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on 2007-003635-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003635-23.